Key Record Dates
ClinicalTrials.gov Identifier: | NCT05271409 |
---|---|
Brief Title: | A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (Meteoroid) |
First Submitted : | February 28, 2022 |
First Submitted that Met QC Criteria : | February 28, 2022 |
First Posted : | March 9, 2022 |
Last Update Submitted that Met QC Criteria : | April 30, 2024 |
Last Update Posted : | May 1, 2024 |